CSR Program: Bridges to Development | Takeda Pharmaceuticals
Providing care and treatment against neglected tropical diseases, empowering communities, training health workers and strengthening health systems
Over 1.5 billion people worldwide are affected by neglected tropical diseases (NTD) even though early prevention and treatment are available. Many hard-to-reach communities of the Pacific islands remain at high risk for NTD infections and carry a disproportionate burden of these diseases. This partnership helps decrease the burden and removes the need for any large-scale interventions against NTDs in the future by eliminating and controlling targeted NTDs (lymphatic filariasis, yaws, leprosy, trachoma, scabies and soil-transmitted helminthiases).